The tweet was deleted by the author.
But we saved everything 🙂.
Strategy (MSTR, formerly MicroStrategy) is trading at $122.87, up modestly since yesterday's close. The intraday move has been neutral, with the price fluctuating in a moderate range for a gain that leaves MSTR nearly unchanged after the open. Today's rebound is primarily driven by oversold technical indicators rather than fundamental news, while positive statements from Michael Saylor offer supportive sentiment but have not produced decisive upward momentum.
Michael Saylor stated, 'Bitcoin is Digital Capital. Strategy transforms it into Digital Credit and Digital Equity. Bringing $STRC and $MSTR onchain is another step toward capital markets that never close.' This message is positive for MSTR, as it highlights a vision for enhanced adoption and liquidity through onchain integration, which could strengthen market sentiment. However, the market remains cautious, prioritizing near-term concerns such as persistent technical weakness and company-specific events over the optimistic outlook from Saylor. Meanwhile, the company has recently raised $284 million via equity sales, repurchased STRC preferred shares, and added to its Bitcoin holdings, further reinforcing its pivot toward Bitcoin treasury management.
View post on X Loading...
MSTR trades below its MA-20 ($138.30), MA-50 ($144.11), and MA-200 ($133.35), indicating sustained selling pressure across all key timeframes. Immediate resistance stands at $143.57, while short-term support is near round-number levels just below the current price, with momentum signals such as MACD, RSI, and Stochastic RSI pointing to ongoing bearishness and oversold conditions. A realistic 5-day trading range is between $118 and $127, with sideways action expected unless $118 or $143.57 are breached. The tweet's bullish signal has not been validated by price action, which adds caution to the near-term forecast.
Previously it was reported that Strategy faced potential billions in forced institutional share sales if removed from MSCI equity indexes due to new eligibility rules. The current article adds a new dimension by examining how recent developments may affect the company’s capital access, with investors advised to monitor upcoming portfolio rebalancing dates as a key risk indicator.